Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993694 · ClinicalTrials.gov registry record
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 41
- Enrollment target
NCT00993694: Completed study, sponsored by Vanderbilt University.
NCT00993694 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00993694 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at methemoglobinemia in young patients with hematologic cancer or aplastic anemia treated with dapsone.
Interventions
- OTHER medical chart review
- DRUG chemotherapy
- PROCEDURE assessment of therapy complications
- DRUG dapsone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
What the finished NCT00993694 record still lists
NCT00993694 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which medical chart review is the first listed.
NCT00993694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00993694 about?
NCT00993694 is a clinical study titled "Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone". RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at methemoglobinemia in young pa...
What is the current status of trial NCT00993694?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00993694?
The interventions under investigation include: medical chart review (OTHER), chemotherapy (DRUG), assessment of therapy complications (PROCEDURE), dapsone (DRUG).
Who is sponsoring clinical trial NCT00993694?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia